Actual Medicinal Product (AMP) Buspirone 5mg tablets (Almus Pharmaceuticals Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Moisture sensitive medicine. Store in airtight (sealed) MCA. Protect from light No stability data in MCAs available
- Provenance
-
This recommendation is based on the products buspirone hydrochloride 5mg tablets (Strides Pharma UK Ltd) and buspirone hydrochloride 5mg tablets (Mylan).
- Generic
- Buspirone
- Formulation
- Buspirone 5mg tablets
-
Buspirone
-
Buspirone 5mg tablets
-
Buspirone 5mg tablets (Almus Pharmaceuticals Ltd)
-
-
Buspirone 30mg tablets